UK: A recent study finds that acute exercise suppresses colorectal cancer progression by altering the circulating proteome, ...

Tempus AI (NASDAQ:TEM) saw its shares pop after announcing a new AI powered tool aimed squarely at improving how certain cancers are identified and treated. The company launched HRD RNA, an algorithm ...

A research team affiliated with UNIST has unveiled a novel approach to halt the progression of colorectal cancer by inducing irreversible cellular aging. Their findings demonstrate that suppressing a ...

A reanalysis of whole-genome data from 130 children conceived after the Chernobyl disaster has identified a statistically ...

Therapeutic mRNA delivered via lipid nanoparticles restored sperm production in genetically infertile mice and produced live ...

Jacob Funds, a mutual fund company, released its fourth-quarter 2025 investor letter. A copy of the same can be downloaded here. After an optimistic quarter, equity markets corrected slightly in ...

Suppliers are investing in production to support deals with AstraZeneca, Bayer and other drugmakers that are advancing radioisotope-based cancer therapies.

Retrotransposons are pivotal in human genome evolution, driving structural variation and regulatory innovation while influencing health and disease.

Dr Constantinos Patinios, a researcher at the EMBL Partnership Institute at Vilnius University Life Sciences Center (VU LSC), ...

University of Queensland research has revealed that double-stranded RNA-based biopesticides (dsRNA) sprayed on plant leaves ...

Beam Therapeutics (BEAM) is back in focus after securing an expedited FDA approval pathway for its BEAM-302 program in alpha-1 antitrypsin deficiency, alongside a standby patent license with Kobe ...

Every day, we bring you the best and worst performers from the previous night in the NBA. This content may be blocked in parts of Europe due to GDPR. To use it, connect your VPN to a non-EU country ...